2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) Guideline: Management of Castration-Resistant Prostate Cancer (CRPC)

This clinical practice guideline is for patients with castration-resistant prostate cancer (CRPC). The guideline examines the management options available for these patients. Specific topics addressed include androgen-deprivation therapy (ADT), the addition or change of first-generation androgen receptor antagonists, and non-metastatic CRPC (nmCRPC).